Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Total article views   HTML views PDF downloads Totals
5,237 Dovepress* 5,039+ 168 5,207
PubMed Central* 198 88 286
Totals 5,237 256 5,493
*Since 13 November 2021

View citations on PubMed Central and Google Scholar